Web Menu

Product Search

Language

Share

Respiratory Disease
Home / Products / Colloidal Gold Platform / Respiratory Disease / Flu A&B&SARS-Cov-2&RSV&ADV Combo test
Colloidal Gold Platform Fluorescence Platform Veterinary Platform Molecular Platform
Flu A&B&SARS-Cov-2&RSV&ADV Combo test

Flu A&B&SARS-Cov-2&RSV&ADV Combo test

FLU A & B & SARS-Cov-2 & RSV& ADV Combo Rapid Test Device (Nasopharyngeal /Nasal Swab) is an in vitro diagnostic test for the qualitative detection of novel coronavirus antigens, influenza A & B antigens, RSV antigens, Adv antigens in Nasopharyngeal Swab/Nasal Aspirate, using the rapid immunochromatographic method. It will provide information for clinical doctors to prescribe correct medications. For professional use only.

Contact Us
Product Features

Product Highlights：

5 in 1 Combo test

Easy to use with filled buffer tubes

Accurate results are available within 15 minutes.

Product Specification

Specification

Test Parameter  FLU A & B & SARS-Cov-2 & RSV& ADV
Test Principle Immunochromatographic method
Sample Type Nasopharyngeal / Nasal Swab
Sample Volume  80μL (Each sample well)
Test Test 15~20 minutes
Operation Temperature 15-30℃
Storage Temperature 2-30℃
Shelf Life 24 months
Qualification CE mark

Feedback
Send
Zhejiang Wantaifu Biotechnology Co., Ltd.
Zhejiang Wantaifu Biotechnology Co., Ltd., established in 2022, is now located in Hangzhou Bay Life Science Park, Economic and Technological Development Zone, Xiaoshan District, Hangzhou. It is an integrated innovative enterprise.

we are China wholesale Flu A&B&SARS-Cov-2&RSV&ADV Combo test manufacturers and OEM Flu A&B&SARS-Cov-2&RSV&ADV Combo test factory. The production center has 100,000-level automatic production lines, which provide effective guarantee for the high precision and high efficiency of products, convenient for customers to do flexible customization, design and processing of precision consumables.

Who

we are

30 Million
Registered capital
130 +
Employees
2022
was founded in
100 Million
Total investment
Our Latest News and Exhibitions
Does the WNE-96 have features to minimize cross-contamination between samples? Yes, the WNE-96 Nucleic Acid Purification Instrument typically includes several features designed to minimize cross-contamination between samples. The... 21-02-2025
What steps are taken to minimize false positives or false negatives in tropical disease rapid tests? Minimizing false positives and false negatives is critical for the reliability and effectiveness of tropical disease rapid tests. False results can le... 14-02-2025
How does the fluorescence immunoassay analyzer account for the effects of fluorescence quenching by hemoglobin or bilirubin in clinical samples? Fluorescence quenching by hemoglobin, bilirubin, or other interfering substances in clinical samples can lead to decreased signal intensity and affect... 08-02-2025
How can the use of Typhoid Antigen Rapid Tests contribute to reducing the spread of typhoid fever in high-risk populations? The use of Typhoid Antigen Rapid Tests (TARTs) can significantly contribute to reducing the spread of typhoid fever in high-risk populations through s... 01-02-2025
How can the widespread use of Typhoid Antigen Rapid Tests help reduce the burden of typhoid fever in endemic regions? The widespread use of Typhoid Antigen Rapid Tests (TARTs) can play a pivotal role in reducing the burden of typhoid fever in endemic regions through s... 25-01-2025
What are the potential limitations of the Leishmania IgG/IgM rapid test in terms of false positives or negatives? The Leishmania IgG/IgM rapid test is a valuable diagnostic tool for detecting leishmaniasis, but like any diagnostic test, it has potential limitation... 17-01-2025
honor